322 related articles for article (PubMed ID: 26899373)
1. Delta-pgm, a new live-attenuated vaccine against Brucella suis.
Czibener C; Del Giudice MG; Spera JM; Fulgenzi FR; Ugalde JE
Vaccine; 2016 Mar; 34(13):1524-1530. PubMed ID: 26899373
[TBL] [Abstract][Full Text] [Related]
2. Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties.
Czibener C; Rey Serantes DA; Romani AM; Bruno L; Pasquevich KA; Cassataro J; Comerci DJ; Ugalde JE
Vaccine; 2023 May; 41(23):3534-3543. PubMed ID: 37149444
[TBL] [Abstract][Full Text] [Related]
3. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
5. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
[TBL] [Abstract][Full Text] [Related]
6. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
7. Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic B. suis biovar 2 background.
Aragón-Aranda B; de Miguel MJ; Lázaro-Antón L; Salvador-Bescós M; Zúñiga-Ripa A; Moriyón I; Iriarte M; Muñoz PM; Conde-Álvarez R
Vet Res; 2020 Jul; 51(1):92. PubMed ID: 32703299
[TBL] [Abstract][Full Text] [Related]
8. Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge.
Moustafa D; Garg VK; Jain N; Sriranganathan N; Vemulapalli R
Vaccine; 2011 Jan; 29(4):784-94. PubMed ID: 21109033
[TBL] [Abstract][Full Text] [Related]
9. Rough Brucella neotomae provides protection against Brucella suis challenge in mice.
Jain-Gupta N; Waldrop SG; Tenpenny NM; Witonsky SG; Boyle SM; Sriranganathan N
Vet Microbiol; 2019 Dec; 239():108447. PubMed ID: 31767087
[TBL] [Abstract][Full Text] [Related]
10. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
11. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
12. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
[TBL] [Abstract][Full Text] [Related]
13. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
[TBL] [Abstract][Full Text] [Related]
14. Duplex PCR for differentiation of the vaccine strain Brucella suis S2 and B. suis biovar 1 from other strains of Brucella spp.
Nan W; Tan P; Wang Y; Xu Z; Mao K; Peng D; Chen Y
Vet J; 2014 Sep; 201(3):427-8. PubMed ID: 25011712
[TBL] [Abstract][Full Text] [Related]
15. Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.
Smith GP; Jain-Gupta N; Alqublan H; Dorneles EMS; Boyle SM; Sriranganathan N
Vaccine; 2019 Feb; 37(7):910-914. PubMed ID: 30655173
[TBL] [Abstract][Full Text] [Related]
16. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
[TBL] [Abstract][Full Text] [Related]
17. Immune responses and protection induced by Brucella suis S2 bacterial ghosts in mice.
Liu J; Li Y; Sun Y; Ji X; Zhu L; Guo X; Zhou W; Zhou B; Liu S; Zhang R; Feng S
Vet Immunol Immunopathol; 2015 Aug; 166(3-4):138-44. PubMed ID: 26022514
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis.
Smither SJ; Perkins SD; Davies C; Stagg AJ; Nelson M; Atkins HS
Clin Vaccine Immunol; 2009 May; 16(5):779-83. PubMed ID: 19321692
[TBL] [Abstract][Full Text] [Related]
19. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
20. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
